Medtronic’s ambitious goal: Generate $40B in free cash flow in 5 years — 6 highlights

Spinal Tech

Here are six highlights from Medtronic's recent investor day, according to a Seeking Alpha report.

1. Medtronic's goal is to generate $40 billion in free cash flow over the next five years, with half returned to shareholders as dividends and buybacks.

 

2. The company will allocate $10 billion of the $40 billion in free-cash-flow to debt reduction and bolt-on mergers and acquisitions. The remaining $10 is slated for flexible options including "bolstering the company's cash position."

 

3. Medtronic intends to achieve mid-single digit constant currency revenue growth in the next five years, as well as double-digit constant currency EPS.

 

4. Every Medtronic division plans to drive innovation and new product development. While the cardiac and vascular market is expected to grow at a 4 percent CAGR, the company wants to grow at a 9 percent CAGR.

 

5. Medtronic is benefiting from its Covidien merger and a marginally lower tax rate from relocating headquarters from the United States to Ireland; which has resulted in a 200 to 300 bps.

 

6. Medtronic will likely have access to 75 percent of the ongoing free-cash flow generation by 2021.

"Medtronic has ambitious growth plans over the next five years. Personally I am skeptical all the targets can be hit," concluded the article's author.

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy.
 

Articles We Think You'll Like